electroCore Donates gammaCore Sapphire for Real World Evaluation of nVNS in Trauma Among Israelis
electroCore, Inc. (ECOR)
Last electrocore, inc. earnings: 3/23 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
ROCKAWAY, N.J., Nov. 19, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it has donated 20 gammaCore Sapphire D’s to be used by Dr. Robin Ely, Director of Integrative and Regenerative Medicine, a global practice focused on the development of integrated treatment regimens for neurocognitive and neurodegenerative disorders, and Dr. Yori Gidron, professor of health psychology at the Dept. of Nursing, Faculty of welfare and health sciences, University of Haifa and co-author of the PTSD Clinical Practice Guideline published by the Vagus Nerve Society. The real-world evaluation will be conducted by Dr. Gidron among Israelis dealing with trauma. Peter Staats, MD, Chief Medical Officer of electroCore, commented, “PTSD remains a serious condition affecting the general population, and especially veterans and members of active-duty military, with limited therapeutic options. We are greatly apprecia
Show less
Read more
Impact Snapshot
Event Time:
ECOR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ECOR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ECOR alerts
High impacting electroCore, Inc. news events
Weekly update
A roundup of the hottest topics
ECOR
News
- electroCore, Inc. (NASDAQ: ECOR) had its price target raised by analysts at HC Wainwright from $22.00 to $25.00. They now have a "buy" rating on the stock.MarketBeat
- electroCore to Acquire NeuroMetrix, Gaining Access to its Quell Platform and Positioning Itself as a Significant Player in Non-Invasive Bioelectronic Medicine and WellnessGlobeNewswire
- electroCore’s Truvaga™ Plus Wins Woman’s World Magazine 50 over 50 AwardGlobeNewswire
- electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21GlobeNewswire
- electroCore Inc (ECOR) Q3 2024 Earnings Call Highlights: Record Revenue Growth Amidst Challenges [Yahoo! Finance]Yahoo! Finance
ECOR
Earnings
- 11/13/24 - Miss
ECOR
Sec Filings
- 12/17/24 - Form 8-K
- 11/29/24 - Form 424B5
- 11/29/24 - Form 8-K
- ECOR's page on the SEC website